Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GRN-300 by Greenfire Bio for Prostate Cancer: Likelihood of Approval
GRN-300 is under clinical development by Greenfire Bio and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...
GRN-300 by Greenfire Bio for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
GRN-300 is under clinical development by Greenfire Bio and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...
GRN-300 by Greenfire Bio for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
GRN-300 is under clinical development by Greenfire Bio and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...